Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 20 July 2010
[DOI: 10.1126/scisignal.2000807]

Supplementary Materials for:

Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration

Achla Gupta, Jan Mulder, Ivone Gomes, Raphael Rozenfeld, Ittai Bushlin, Edmund Ong, Maribel Lim, Emeline Maillet, Mats Junek, Catherine M. Cahill, Tibor Harkany, Lakshmi A. Devi*

*To whom correspondence should be addressed. E-mail: lakshmi.devi{at}mssm.edu

This PDF file includes:

  • Materials and Methods
  • Fig. S1. Generation and characterization of μ-δ heteromer–selective antibodies.
  • Fig. S2. Subcellular distribution and colocalization of μ and δ opioid receptors.
  • Fig. S3. Chronic morphine treatment induces increased μ-δ heteromer
    immunoreactivity in the brainstem.
  • Fig. S4. Chronic morphine treatment increases μ-δ heteromer abundance.
  • Fig. S5. μ-δ heteromer–selective antibodies block heteromer-mediated binding and
    signaling.
  • Table S1. Characterization of select hybridoma clones.
  • Table S2. Heteromer-selective antibody recognition using chimeric μ-δ constructs.
  • References

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 3,126 KB


Citation: A. Gupta, J. Mulder, I. Gomes, R. Rozenfeld, I. Bushlin, E. Ong, M. Lim, E. Maillet,
M. Junek, C. M. Cahill, T. Harkany, L. A. Devi, Increased Abundance of Opioid Receptor
Heteromers After Chronic Morphine Administration. Sci. Signal. 3, ra54 (2010).

© 2010 American Association for the Advancement of Science


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882